biotech company Archives

Clinical Research, Pharma & Healthcare Financing

PeproMene, IFLI: First FL Patient on BAFF-R CAR-T Sees Complete Response

PR NewswireMay 26, 2025May 27, 2025

by PR NewswireMay 26, 2025May 27, 2025012

PeproMene Bio, Inc. (PMB) a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first r/r FL patient treated...

Clinical Research, Pharma & Healthcare Financing

OLYMPUS Study Reports 4-Year Response in Urothelial Cancer Patients

Business WireApril 28, 2025April 29, 2025

by Business WireApril 28, 2025April 29, 2025037

Data Presented at the 2025 American Urological Association Annual Meeting in Las Vegas, Nevada UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing...

Workforce Development & Leadership

AI Proteins CEO to Speak at TED on Miniprotein Therapeutics

Business WireApril 8, 2025April 9, 2025

by Business WireApril 8, 2025April 9, 2025034

AI Proteins, a Boston-based biotech company pioneering the design of novel miniprotein therapeutics, today announced that its President, CEO, and Founder, Chris Bahl, will be...

Workforce Development & Leadership

iOncologi Appoints Dr. Mona Flores and Mr. Paolo Fundarò to Board

PR NewswireMarch 17, 2025March 18, 2025

by PR NewswireMarch 17, 2025March 18, 2025046

iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer treatment, today announced the appointment of Dr. Mona Flores and Mr. Paolo Fundarò to its...

Workforce Development & Leadership

Shift Bioscience Announces Key Appointments for Pipeline Growth

Business WireMarch 12, 2025March 18, 2025

by Business WireMarch 12, 2025March 18, 2025056

Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, announced the appointments of Jill Reckless, Ph.D, as Translation Advisor...

Clinical Research, Pharma & Healthcare Financing

Orbis Medicines Appoints Mikael Dolsten as Board Chair

Business WireMarch 5, 2025March 6, 2025

by Business WireMarch 5, 2025March 6, 2025051

Orbis Medicines, a leader in oral macrocycle drug discovery, today announces the appointment of Mikael Dolsten, M.D., Ph.D., former Chief Scientific Officer, President, Pfizer Research...

Tag : biotech company

PeproMene, IFLI: First FL Patient on BAFF-R CAR-T Sees Complete Response

OLYMPUS Study Reports 4-Year Response in Urothelial Cancer Patients

AI Proteins CEO to Speak at TED on Miniprotein Therapeutics

iOncologi Appoints Dr. Mona Flores and Mr. Paolo Fundarò to Board

Shift Bioscience Announces Key Appointments for Pipeline Growth

Orbis Medicines Appoints Mikael Dolsten as Board Chair

The Leadership Development Playbook for Gen Z and...

Top Three Rewards Programs to Inspire From in...

Securing Data Pipelines: Trends in Telecom Cybersecurity

Cross-Industry Collaborations for Future-Ready Talent

Buying a Home With Friends? Treat It Like...

Quick Links

Stay up to date